UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 80

Sortiert nach

PARP inhibitors in breast cancer: Bringing synthetic lethality to the bedside

Cancer, 2018-06, Vol.124 (12), p.2498-2506

2018

Volltextzugriff (PDF)

A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782)

Cancer medicine (Malden, MA), 2022-11, Vol.11 (21), p.3969-3981

2022

Volltextzugriff (PDF)

Acceptance and commitment therapy for fatigue interference in advanced gastrointestinal cancer and caregiver burden: protocol of a pilot randomized controlled trial

Pilot and feasibility studies, 2021-04, Vol.7 (1), p.99-99, Article 99

2021

Volltextzugriff (PDF)

Acceptance and commitment therapy for patient fatigue interference and caregiver burden in advanced gastrointestinal cancer: Results of a pilot randomized trial

Palliative medicine, 2022-07, Vol.36 (7), p.1104-1117

2022

Volltextzugriff (PDF)

Impact of acceptance and commitment therapy on physical and psychological symptoms in advanced gastrointestinal cancer patients and caregivers: Secondary results of a pilot randomized trial

Journal of contextual behavioral science, 2023-01, Vol.27, p.107-115

2023

Volltextzugriff (PDF)

Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study

The lancet oncology, 2023-05, Vol.24 (5), p.496-508

2023

Volltextzugriff (PDF)

Molecular Profiles Guide Colorectal Cancer Treatment

Federal practitioner, 2016-05, Vol.33 (Suppl 4), p.50S-53S

2016

Volltextzugriff (PDF)

Synthesis, spectroscopic, electrochemical, thermal and antimicrobial studies of Ni(II), Zn(II), Cu(II) and Co(II) metal complexes of novel bidentate schiff base ligand

Journal of the Iranian Chemical Society, 2022-09, Vol.19 (9), p.3797-3813

2022

Volltextzugriff (PDF)

Efficacy of Using Probiotics with Antagonistic Activity against Pathogens of Wound Infections: An Integrative Review of Literature

BioMed research international, 2019, Vol.2019, p.7585486-21

2019

Volltextzugriff (PDF)

Synthesis, spectral characterization, and antimicrobial evaluation of new imine derived from 3‐methylthiophene‐2‐carboxaldehyde and its Co(II), Ni(II), Cu(II), and Zn(II) metal complexes

Applied organometallic chemistry, 2021-04, Vol.35 (4), p.n/a

2021

Volltextzugriff (PDF)

PARP Inhibition in BRCA-Mutant Breast Cancer

Cancer, 2018-04, Vol.124 (12), p.2498-2506

2018

Volltextzugriff (PDF)

FLUOROURACIL INDUCED CORONARY VASOSPASM: A SUCCESSFUL INFUSION RECHALLENGE FOLLOWING PRETREATMENT PROPHYLAXIS

Journal of the American College of Cardiology, 2023-03, Vol.81 (8), p.3441-3441

2023

Volltextzugriff (PDF)

New Palladium(II) complexes of 2-arylidene-1-(4-methyl-6-phenyl-pyrimidin-2-yl)hydrazines: synthesis, spectroscopic characterization, biological evaluation and protein binding

Journal of the Iranian Chemical Society, 2021-12, Vol.18 (12), p.3327-3340

2021

Volltextzugriff (PDF)

Heteroleptic six-coordinate bismuth() complexes with 2-acetylthiophene thiosemicarbazones: synthesis, characterization, and biological properties

New journal of chemistry, 2023-07, Vol.47 (27), p.12779-12789

2023

Volltextzugriff (PDF)

Synthesis, characterization, and biological properties of mono-, di- and poly-nuclear bismuth(III) halide complexes containing thiophene-2-carbaldehyde thiosemicarbazones

Journal of inorganic biochemistry, 2022-12, Vol.237, p.111987-111987, Article 111987

2022

Volltextzugriff (PDF)

Phase I study of trifluridine/tipiracil in combination with gemcitabine (gem) and nab-paclitaxel (nab-P) in patients (pts) with advanced pancreatic ductal adenocarcinoma (PDAC)

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.731-731

2023

Volltextzugriff (PDF)

Molecular insights into clinical trials for immune checkpoint inhibitors in colorectal cancer: Unravelling challenges and future directions

World journal of gastroenterology : WJG, 2024-04, Vol.30 (13), p.1815-1835

2024

Volltextzugriff (PDF)

A phase 2 basket trial of an ERK1/2 inhibitor (LY3214996) in combination with abemaciclib for patients whose tumors harbor pathogenic alterations in BRAF , RAF1 , MAP2K1/2 ERK1/2 , and NF1

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e15088-e15088

2023

Volltextzugriff (PDF)

Milk and serum proteomes in subclinical and clinical mastitis in Simmental cows

Journal of proteomics, 2021-07, Vol.244, p.104277-104277, Article 104277

2021

Volltextzugriff (PDF)

BTCRC-GI20-457: A phase II study of atezolizumab and bevacizumab in Child-Pugh B7 hepatocellular carcinoma (the AB7 Trial)

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.TPS493-TPS493

2022

Volltextzugriff (PDF)

Refining colorectal cancer classification and clinical stratification through a single-cell atlas

Genome Biology, 2022-05, Vol.23 (1), p.113-113, Article 113

2022

Volltextzugriff (PDF)

A phase II trial of cabozantinib and erlotinib for patients with EGFR and c-Met co-expressing metastatic pancreatic adenocarcinoma (PDAC)

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e16764-e16764

2020

Volltextzugriff (PDF)

A phase II, open-label pilot study evaluating the safety and activity of liposomal irinotecan (Nal-IRI) in combination with 5-FU and oxaliplatin (NALIRIFOX) in preoperative treatment of pancreatic adenocarcinoma (NEO-Nal-IRI Study)

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.TPS778-TPS778

2023

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(77)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(28)
Life Sciences & Biomedicine
(24)
Humans
(19)
Oncology
(8)
Female
(7)
Male
(6)
Middle Aged
(6)
Patients
(6)
Aged
(5)
Cancer
(5)
Chemistry
(5)
Colorectal Cancer
(5)
Ligands
(5)
Physical Sciences
(5)
Public, Environmental & Occupational Health
(5)
Biochemistry & Molecular Biology
(4)
Cancer Therapies
(4)
Chemotherapy
(4)
Clinical Trials
(4)
E Coli
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(19)
Arhiv Za Higijenu Rada I Toksikologiju
(7)
Cancer Research
(4)
Cancer
(2)
Genome Biology
(2)
Journal Of The Iranian Chemical Society
(2)
Molecular Cell
(2)
Neurology
(2)
Sigurnost
(2)
The Oncologist
(2)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

PARP inhibitors in breast cancer: Bringing synthetic lethality to the bedside

A phase I study of talazoparib (BMN 673) combined with carboplatin and paclitaxel in patients with advanced solid tumors (NCI9782)

Acceptance and commitment therapy for fatigue interference in advanced gastrointestinal cancer and caregiver burden: protocol of a pilot randomized controlled trial

Acceptance and commitment therapy for patient fatigue interference and caregiver burden in advanced gastrointestinal cancer: Results of a pilot randomized trial

Impact of acceptance and commitment therapy on physical and psychological symptoms in advanced gastrointestinal cancer patients and caregivers: Secondary results of a pilot randomized trial

Making National Cancer Institute-Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study

Tucatinib plus trastuzumab for chemotherapy-refractory, HER2-positive, RAS wild-type unresectable or metastatic colorectal cancer (MOUNTAINEER): a multicentre, open-label, phase 2 study

Abstract CT098: A first-in-human phase 1 study of LY3410738, a covalent inhibitor of mutant IDH, in advanced IDH-mutant cholangiocarcinoma and other solid tumors

Molecular Profiles Guide Colorectal Cancer Treatment

Synthesis, spectroscopic, electrochemical, thermal and antimicrobial studies of Ni(II), Zn(II), Cu(II) and Co(II) metal complexes of novel bidentate schiff base ligand

Efficacy of Using Probiotics with Antagonistic Activity against Pathogens of Wound Infections: An Integrative Review of Literature

Synthesis, spectral characterization, and antimicrobial evaluation of new imine derived from 3‐methylthiophene‐2‐carboxaldehyde and its Co(II), Ni(II), Cu(II), and Zn(II) metal complexes

PARP Inhibition in BRCA-Mutant Breast Cancer

FLUOROURACIL INDUCED CORONARY VASOSPASM: A SUCCESSFUL INFUSION RECHALLENGE FOLLOWING PRETREATMENT PROPHYLAXIS

New Palladium(II) complexes of 2-arylidene-1-(4-methyl-6-phenyl-pyrimidin-2-yl)hydrazines: synthesis, spectroscopic characterization, biological evaluation and protein binding

Heteroleptic six-coordinate bismuth() complexes with 2-acetylthiophene thiosemicarbazones: synthesis, characterization, and biological properties

Synthesis, characterization, and biological properties of mono-, di- and poly-nuclear bismuth(III) halide complexes containing thiophene-2-carbaldehyde thiosemicarbazones

Phase I study of trifluridine/tipiracil in combination with gemcitabine (gem) and nab-paclitaxel (nab-P) in patients (pts) with advanced pancreatic ductal adenocarcinoma (PDAC)

Molecular insights into clinical trials for immune checkpoint inhibitors in colorectal cancer: Unravelling challenges and future directions

A phase 2 basket trial of an ERK1/2 inhibitor (LY3214996) in combination with abemaciclib for patients whose tumors harbor pathogenic alterations in BRAF , RAF1 , MAP2K1/2 ERK1/2 , and NF1

Milk and serum proteomes in subclinical and clinical mastitis in Simmental cows

BTCRC-GI20-457: A phase II study of atezolizumab and bevacizumab in Child-Pugh B7 hepatocellular carcinoma (the AB7 Trial)

Refining colorectal cancer classification and clinical stratification through a single-cell atlas

A phase II trial of cabozantinib and erlotinib for patients with EGFR and c-Met co-expressing metastatic pancreatic adenocarcinoma (PDAC)

A phase II, open-label pilot study evaluating the safety and activity of liposomal irinotecan (Nal-IRI) in combination with 5-FU and oxaliplatin (NALIRIFOX) in preoperative treatment of pancreatic adenocarcinoma (NEO-Nal-IRI Study)

Suchergebnisse filtern